Quantitative Measurement of Acute Myocardial Infarction Cardiac Biomarkers by "All-in-one" Immune Microfluidic Chip for Early Diagnosis of Myocardial Infarction.

Zhaokui Zeng,Huimin Li,Qi Li,Ruowei Sun,Xun Zhang,Di Zhang,Qubo Zhu,Chuanpin Chen
DOI: https://doi.org/10.1016/j.saa.2024.124256
2024-01-01
Abstract:Acute myocardial infarction (AMI) is a life-threatening condition with a narrow treatment window, necessitating rapid and accurate diagnostic methods. We present an "all-in-one" convenient and rapid immunoassay system that combines microfluidic technology with a colloidal gold immunoassay. A degassing-driven chip replaces a bulky external pump, resulting in a user-friendly and easy-to-operate immunoassay system. The chip comprises four units: an inlet reservoir, an immunoreaction channel, a waste pool, and an immunocomplex collection chamber, allowing single-channel flow for rapid and accurate AMI biomarker detection. In this study, we focused on cardiac troponin I (cTnI). With a minimal sample of just 4 μL and a total detection time of under 3 min, the chip enabled a quantitative visual analysis of cTnI concentration within a range of 0.5 ∼ 60.0 ng mL-1. This all-in-one integrated microfluidic chip with colloidal gold immunoassay offers a promising solution for rapid AMI diagnosis. The system's portability, small sample requirement, and quantitative visual detection capabilities make it a valuable tool for AMI diagnostics.
What problem does this paper attempt to address?